Jacob is an Associate with more than 6 years of experience across a variety of areas within the Financial Services industry including Investment Banking, Venture Capital, Risk, and Wealth Management.
Before joining Accordion, Jacob worked at Ligo Partners, a multi-family office consortium that co-invests in disruptive tech-focused deals sourced from top VC firms across major US tech hubs. He primarily focused on sourcing disruptive healthcare technology companies looking to close Seed to Series B funding rounds.
Prior to Ligo, he was an Investment Banking Associate at Berenberg Capital Markets for the Equity Capital Markets team. There, he participated in the execution of several transactions including IPOs, capital raises, secondary offerings, and at-the-market offerings to a variety of small to mid-cap North American and European clients. A notable transaction includes the completion of the pre-placement and rights offering for BioNTech. Prior to Berenberg, he served as an Investment Banking Analyst at Eureka Capital Partners where he focused on mergers & acquisitions, strategic advisory and divestiture transactions across the healthcare, consumer, business services, and industrial sectors.
Jacob began his financial career at Barclays Capital working in the Risk and Wealth Management divisions where he focused on new business initiatives and was a part of the successful wind down of Barclays Wealth after it was acquired by Stifel.
Jacob graduated with honors from Syracuse University with a Bachelor of Science in Finance and Marketing Management.
“Don’t fear failure…in great attempts it is glorious even to fail.” – Bruce Lee